![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
BYETTA Approved for Use with Insulin Glargine in the U.S.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company announced that the U.S. Food and...
EMA recognizes Takeda’s pioglitazone-containing medicines remain a valid treatment option for appropriate type 2...
Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the...
Vertex Submits Application for Priority Review and Approval of KALYDECO
Vertex Pharmaceuticals Incorporated announced the submission of a New Drug Application (NDA) to the...
Norgine and Jubilant Announce Discovery Collaboration in Gastrointestinal Therapeutic Area
Norgine, a leading European speciality pharmaceutical company and Jubilant Biosys Ltd., Bengaluru based subsidiary...
Oxford BioMedica Announces US IND Approval for Novel Ocular Product
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, announces that the US Food and Drug...
Agilent Technologies and Oxford Gene Technology Expand Microarray and Sequencing Partnership
Agilent Technologies Inc. and Oxford Gene Technology today announced they have expanded an existing...
Teva Completes Acquisition of Cephalon
Teva Pharmaceutical Industries Ltd.announced that it has completed its acquisition of Cephalon, Inc. (NASDAQ: CEPH). ...
Ranbaxy Honored With Nabia Award For Excellence in New Jersey Business Expansion
Ranbaxy Inc., a research-based pharmaceutical company that manufactures generic product formulations, OTC and branded...
AstraZeneca sticks to R&D partnership track in China
As global pharmas race to grab a piece of the growing Chinese drug market,...
Sanofi Pasteur Donates Vaccine Strain Used for Polio Eradication to WHO
Sanofi Pasteur, the vaccines division of Sanofi is donating to the World Health Organization...